New tetrahydro-isoquinoline derivatives as cholinesterase and α-glycosidase inhibitors: Synthesis, characterization, molecular docking & dynamics, ADME prediction, in vitro cytotoxicity and enzyme inhibition studies

99 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

1. 2025 Development of phenolic Mannich bases as α-glucosidase and aldose reductase inhibitors: In vitro and in silico approaches for managing diabetes mellitus and its complicationsCitations 45 · OpenAlex
2. 2026 Morpholine-modified thiosemicarbazones and thiazolidin-4-ones against Alzheimer's key enzymes: From synthesis to inhibitionCitations 42 · OpenAlex
3. 2025 Morpholine-modified thiosemicarbazones and thiazolidin-4-ones against Alzheimer’s key enzymes: From synthesis to inhibitionCitations 42 · OpenAlex
4. 2026 Morpholine-modified thiosemicarbazones and thiazolidin-4-ones against Alzheimer’s key enzymes: From synthesis to inhibitionCitations 41 · OpenAlex
5. 2025 Synthesis and biological studies of acetophenone-based novel chalcone, semicarbazone, thiosemicarbazone and indolone derivatives: Structure-Activity relationship, molecular docking, molecular dynamics, and kinetic studiesCitations 37 · OpenAlex
6. 2025 Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studiesCitations 35 · OpenAlex
7. 2025 Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studiesCitations 34 · OpenAlex
8. 2025 Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studiesCitations 34 · OpenAlex
9. 2025 Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studiesCitations 34 · OpenAlex
10. 2025 Recent Studies on Heterocyclic Cholinesterase Inhibitors Against Alzheimers DiseaseCitations 25 · OpenAlex